SARS-CoV-2 Disguise Study
Disguise
SARS-CoV-2 Positive Carriers Among Asymptomatic meDIcal employeeS in hiGh-volUme cardIovaScular cEnter
1 other identifier
observational
900
1 country
1
Brief Summary
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a pandemic disease with worldwide spreading. Limited data are existed regarding SARS-CoV-2 positive carriers among asymptomatic medical employees in non-profile infectious clinic, e.g. cardiovascular clinic, routinely working in the pandemic region with two million inhabitants. The aim is to test the percentage and increase of the SARS-CoV-2 positive carriers among asymptomatic medical employees in high-volume cardiovascular center in routine clinical practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 7, 2020
CompletedFirst Submitted
Initial submission to the registry
May 19, 2020
CompletedFirst Posted
Study publicly available on registry
May 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2020
CompletedMay 20, 2020
May 1, 2020
4 months
May 19, 2020
May 19, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
SARS-CoV-2 positive test
Percentage of SARS-CoV-2 positive tests and increase of SARS-CoV-2 positive test between 1 st , 2 nd and 3 rd time frame testing
8 weeks
Secondary Outcomes (4)
Transformation
8 weeks
Predictors (asymptomatic)
8 weeks
Predictors (symptomatic)
8 weeks
Percentage from different departments
8 weeks
Study Arms (1)
Medical Employees
Asymptomatic medical employees in high-volume cardiovascular center.
Interventions
Nasopharyngeal and oropharyngeal testing for SARS-CoV-2
Questionnaire regarding SARS-CoV-2 symptoms and contact with COVID patients
Eligibility Criteria
Asymptomatic medical employees in high-volume cardiovascular center
You may qualify if:
- Asymptomatic medical employees of E. Meshalkin National Medical Research Center of the Ministry of Health of the Russian Federation
- Filled questionnaire before SARS-CoV-2 testing
- Nasopharyngeal and oropharyngeal testing for SARS-CoV-2
- Signed informed consent
You may not qualify if:
- Unwilling to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Meshalkin National Medical Research Center
Novosibirsk, 630055, Russia
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 8 Weeks
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 19, 2020
First Posted
May 20, 2020
Study Start
May 7, 2020
Primary Completion
August 31, 2020
Study Completion
November 30, 2020
Last Updated
May 20, 2020
Record last verified: 2020-05